MARATTO

letter · Journal of Surgical Oncology

Navigating the complexity of post‐NAT therapy in breast cancer: The role of ctDNA testing

2024Open accessMohammed V University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

Research topics

  • Cancer Genomics and Diagnostics
  • PARP inhibition in cancer therapy
  • Molecular Biology Techniques and Applications

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/jso.27658

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.